Financial News

Recent Quotes

My Watchlist

Indicators

Overview

XRAY Deadline to Lead in Securities Fraud Lawsuit is January 27, 2025 - Contact Kaplan Fox &amp; Kilsheimer LLP

By: TheNewswire.com

December 22, 2024 at 08:00 AM EST

<div>NEW YORK - (<a href="https://www.newmediawire.com">NewMediaWire</a>) - December 22, 2024 - <a href="https://www.kaplanfox.com/?utm_source=NMW&utm_medium=Press+Release&utm_campaign=Dentsply+Sirona&utm_id=Dentsply+Sirona&utm_term=XRAY+NMW">Kaplan Fox & Kilsheimer LLP</a> announces that a class action lawsuit has been filed against DENTSPLY SIRONA Inc. (“DENTSPLY” or the “Company”) (NASDAQ: XRAY) on behalf of investors that purchased or otherwise acquired DENTSPLY securities between May 6, 2021 and November 6, 2024 (the “Class Period”). <a href="https://www.kaplanfox.com/case/dentsply-sirona-inc/?utm_source=NMW&utm_medium=Press+Release&utm_campaign=Dentsply+Sirona&utm_id=Dentsply+Sirona&utm_term=XRAY+NMW">CLICK HERE TO JOIN THE CASE</a> <figure align="left" style="width: 240px; max-width: 100%; margin-bottom: 20px; float: left; margin-right: 20px;"><img src="http://newmediawire.s3.amazonaws.com/67675093da846f3dd21a4a5c_1" alt="" width="240" style="width: 240px; max-width: 100%; height: auto;" /></figure> If you are an investor in DENTSPLY and have suffered losses, you may <a href="https://www.kaplanfox.com/case/dentsply-sirona-inc/?utm_source=NMW&utm_medium=Press+Release&utm_campaign=Dentsply+Sirona&utm_id=Dentsply+Sirona&utm_term=XRAY+NMW">CLICK HERE</a> to contact us. You may also contact Kaplan Fox by emailing <a href="mailto:pmayer@kaplanfox.com">pmayer@kaplanfox.com</a> or by calling (646) 315-9003. DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than January 27, 2025 to serve as a lead plaintiff for the purported class.  If you have losses we encourage you to contact us to learn more about the lead plaintiff process. On October 24, 2024, DENTSPLY issued a press release "announc[ing] the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the Company conducts a review of certain regulatory requirements related to these products."  The press release also states that “[t]he Company’s decision was made in consultation with the U.S. Food and Drug Administration (FDA)." Following this news, the price of DENTSPLY's stock fell $1.10 per share, or 4.5%, to close at $23.31 per share on October 25, 2024. Then, on November 6, 2024, in connection with reporting third quarter financial results, DENTSPLY issued a press release revising its 2024 outlook to reflect that organic sales are expected to be down 3.5% to 2.5% year-over-year compared to its prior outlook that organic sales would be down 1% to flat. Following this news, the price of DENTSPLY’s stock fell $6.72 per share, about 28%, to close at $17.26 per share on November 7, 2024. WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.  With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand.  Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients.  For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at <a href="http://www.kaplanfox.com">www.kaplanfox.com</a>. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this Notice, your rights, or your interests, please contact: CONTACT: Pamela A. Mayer <a href="http://www.kaplanfox.com/">KAPLAN FOX & KILSHEIMER LLP</a> 800 Third Avenue, 38th Floor New York, New York 10022 (646) 315-9003 <a href="mailto:pmayer@kaplanfox.com">pmayer@kaplanfox.com</a> Laurence D. King <a href="http://www.kaplanfox.com/">KAPLAN FOX & KILSHEIMER LLP</a> 1999 Harrison Street, Suite 1560 Oakland, California 94612 (415) 772-4704 <a href="mailto:lking@kaplanfox.com">lking@kaplanfox.com</a>View the original release on <a href="https://www.newmediawire.com/nmw_release/?rid=67675093da846f3dd21a4a5c/xray-deadline-to-lead-in-securities-fraud-lawsuit-is-january-27-2025-contact-kaplan-fox-kilsheimer-llp">www.newmediawire.com</a></div>

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

XRAY Deadline to Lead in Securities Fraud Lawsuit is January 27, 2025 - Contact Kaplan Fox &amp;amp; Kilsheimer LLP

Popular Pages

XRAY Deadline to Lead in Securities Fraud Lawsuit is January 27, 2025 - Contact Kaplan Fox & Kilsheimer LLP